학술논문
BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia
Document Type
Artikel
Author
Zabriskie, MS; Eide, CA; Tantravahi, SK; Vellore, NA; Estrada, J; Nicolini, FE; Khoury, HJ; Larson, RA; Konopleva, M; Cortes, JE; Kantarjian, H; Jabbour, EJ; Kornblau, SM; Lipton, JH; Rea, D; Stenke, L; Barbany, G; Lange, T; Hernandez-Boluda, JC; Ossenkoppele, GJ; Press, RD; Chuah, C; Goldberg, SL; Wetzler, M; Mahon, FX; Etienne, G; Baccarani, M; Soverini, S; Rosti, G; Rousselot, P; Friedman, R; Deininger, M; Reynolds, KR; Heaton, WL; Eiring, AM; Pomicter, AD; Khorashad, JS; Kelley, TW; Baron, R; Druker, BJ; Deininger, MW; O'Hare, T
Source
Cancer cell. 26(3):428-442
Subject
Language
English
English
English
ISSN
1878-3686